View Navigation Search Our Site

Platelet-Oriented Inhibition in New TIA and minor ischemic stroke (POINT) trial IRB

Purpose

The purpose of this study is to examine whether it is better to give one or two blood thinning medications to patients who have just had a transient ischemic attack (TIA) or minor stroke. The two medicines are clopidogrel and aspirin.

Keywords

TIA, stroke, aspirin, POINT, clopidogrel

Principal Investigator

Anna Y Khanna, MD

Department

VASCULAR NEUROLOGY

Contact Information

anna.khanna@neurology.ufl.edu

3522735550

Begin a new search for other research studies

Studies listed on this site have been approved by a UF Institutional Review Board (IRB), which works to ensure the welfare and rights of research participants as required by federal regulations. Study listings are provided by the UF Clinical and Translational Science Institute in collaboration with UF research teams and the UF IRBs.

Be an Informed Participant

Before deciding to participate in a research study, take time to learn about clinical research, how it's conducted and your rights as a research participant. Following are some helpful resources from independent sources. Always remember that a clinical research study is research, not treatment.

Know Who to Contact

  • Eligibility: For questions about a specific study and who is eligible to participate, call or email the contact person listed for that study.
  • Your Rights: For questions about your rights as a research participant, contact the UF Institutional Review Boards at 352-273-9600.
  • Feedback: For general questions or feedback about study listings, email the UF Clinical and Translational Science Institute at UFStudies@health.ufl.edu.

Other Resources

  • HealthStreet: Health-focused services, classes and events, and opportunities to participate in research.
  • ResearchMatch.org: Join a national registry of volunteers willing to be contacted about research studies.

For Research Teams